Ocuphire Pharma, Inc.·4

Feb 1, 4:26 PM ET

Sooch Mina 4

4 · Ocuphire Pharma, Inc. · Filed Feb 1, 2022

Insider Transaction Report

Form 4
Period: 2022-01-28
Sooch Mina
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-01-28+200,000200,000 total
    Exercise: $2.90Exp: 2032-01-27Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The option will vest with respect to 50,000 shares on January 28, 2023, and then with respect to 4,166 shares on the last day of each month from February 2023 through December 2025 and with respect to 4,190 shares at the end of January 2026.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4